Download PDF - Weil, Gotshal & Manges
Download PDF - Weil, Gotshal & Manges
Download PDF - Weil, Gotshal & Manges
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
110 Rule 10C-1(b)(5)(i).<br />
111 NYSE Listed Company Manual Section 303A.05(a).<br />
112 Nasdaq Equity Rule 5605A(d).<br />
113 Nasdaq Equity Rule 5605(d)(2)(A); Nasdaq IM-5605-6. If the compensation committee’s membership falls<br />
below two members or one compensation committee member ceases to be independent “for circumstances outside<br />
the member’s reasonable control,” the listed company ceases to comply with Nasdaq’s listing requirements and must<br />
give notice thereof to Nasdaq. An item 3.01 Form 8-K report must also be filed with the SEC. However, the<br />
company is provided a cure period extending until the earlier of next annual shareholders meeting or one year to<br />
come into compliance; provided, however, that the company shall have a minimum of 180 days to fill the vacancy.<br />
Nasdaq Equity Rule 5605(d)(4).<br />
114 NYSE Listed Company Manual Sections 303A.00, 303A.02(a)(ii) (operative text effective commencing July 1,<br />
2013).<br />
115<br />
NYSE Listed Company Manual Section 303A.00 (operative text effective commencing July 1, 2013);<br />
Commentary to NYSE Listed Company Manual Section 303A.02(a) (operative text effective commencing July 1,<br />
2013).<br />
116 Nasdaq Equity Rules 5605(d)(2)(A), 5605(d)(6).<br />
117 Nasdaq IM-5605-6.<br />
118 NYSE Listed Company Manual Section 303A.00 (operative text effective commencing July 1, 2013).<br />
119 Nasdaq Equity Rule 5605(d)(4).<br />
120 In determining the long-term incentive component of CEO compensation, the committee should consider the<br />
listed company’s performance and relative shareholder return, the value of similar incentive awards to CEOs at<br />
comparable companies, and the awards given to the listed company’s CEO in past years. The compensation<br />
committee is not precluded from approving awards (with or without ratification of the board) as may be required to<br />
comply with applicable tax laws (i.e., Section 162(m) of the Internal Revenue Code of 1986, as amended).<br />
Discussions regarding CEO compensation with the board generally are not precluded, as it is not the intent to impair<br />
communication among board members. Commentary to NYSE Listed Company Manual Section 303A.05.<br />
121 All equity-compensation plans and any material revisions to the terms of such plans are subject to shareholder<br />
approval with limited exceptions. NYSE Listed Company Manual Section 303A.08. Nasdaq has a similar<br />
requirement. See Nasdaq Equity Rule 5635(c).<br />
122 This provision is not intended to preclude a board’s ability to delegate its authority to approve non-CEO<br />
executive officer compensation to the compensation committee. Commentary to NYSE Listed Company Manual<br />
Section 303A.05.<br />
123 NYSE Listed Company Manual Section 303A.05(b)(iii) (operative text effective commencing July 1, 2013).<br />
124 Id. In addition, for all public companies, Nasdaq-listed as well as NYSE listed, Regulation S-K Item 407(e)(3)(iii)<br />
requires annual disclosure relating to compensation consultants. See supra note 105.<br />
125 Commentary to NYSE Listed Company Manual Section 303A.05(b).<br />
126<br />
Nasdaq Equity Rules 5605(d)(1), 5605(d)(6).<br />
<strong>Weil</strong>, <strong>Gotshal</strong> & <strong>Manges</strong> LLP 57<br />
US_ACTIVE:\44182171\7\99980.0865